Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper

European Respiratory Journal

Volumn 42, Issue 2, 2013, Pages 495-503

  Aabye, Martine G ^a   Latorre, Irene ^b   Diaz, Jessica ^b   Maldonado, Jose ^c   Mialdea, Irene ^d   Eugen Olsen, Jesper ^a   Ravn, Pernille ^a,e   Dominguez, Jose ^b   Ruhwald, Morten ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c Hospital Serveis Clinics   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

^e Department of Infectious Diseases   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10;

ARTICLE; BCG VACCINATION; CONTROLLED STUDY; DENMARK; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRIED BLOOD SPOT TESTING; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FILTER; GAMMA INTERFERON INDUCIBLE PROTEIN 10 RELEASE ASSAY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPAIN; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; ALGORITHMS; ANTIGENS, BACTERIAL; CASE-CONTROL STUDIES; CHEMOKINE CXCL10; COHORT STUDIES; DENMARK; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PAPER; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 85047688036     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00129412     Document Type: Article

References (42)

1. Diel R, Goletti D, Ferrara G, et al. Interferon-c release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011; 37: 88-99.
2. Lalvani A, Pareek M. Interferon-c release assays: principles and practice. Enferm Infecc Microbiol Clin 2010; 28: 245-252.
3. Andersen P, Munk ME, Pollock JM, et al. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356: 1099-1104.
4. Lalvani A, Pareek M. A 100 year update on diagnosis of tuberculosis infection. Br Med Bull 2010; 93: 69-84.
5. Ruhwald M, Ravn P. Biomarkers of latent TB infection. Expert Rev Respir Med 2009; 3: 387-401.
6. Ruhwald M, Aabye MG, Ravn P. IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn 2012; 12: 175-187.
7. Kasprowicz VO, Halliday JS, Mitchell J, et al. MIGRAs: are they the new IGRAs? Development of monokineamplified IFN-c release assays. Biomark Med 2012; 6: 177-186.
8. Groom JR, Luster AD. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 2011; 89: 207-215.
9. Guzzo C, Che Mat NF, Gee K. Interleukin-27 induces a STAT1/3- and NF-kB-dependent proinflammatory cytokine profile in human monocytes. J Biol Chem 2010; 285: 24404-24411.
10. Rudner XL, Happel KI, Young EA, et al. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 2007; 75: 3055-3061.
11. Liu M, Guo S, Hibbert JM, et al. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev 2011; 22: 121-130.
12. Aabye MG, Eugen-Olsen J, Werlinrud AM, et al. A simple method to quantitate IP-10 in dried blood and plasma spots. PLoS One 2012; 7: e39228.
13. Mei JV, Alexander JR, Adam BW, et al. Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr 2001; 131: 1631S-1636S.
14. Jepsen M, Krause TG, Moryl D, et al. Sammenligning af QuantiFERON og hudtest ved mulig tuberkuloseinfektion [Comparison of QuantiFERON and tuberculin skin test in possible suspected tuberculosis infection]. Ugeskr Laeger 2009; 171: 2625-2631.
15. Walzl G, Ronacher K, Hanekom W, et al. Immunological biomarkers of tuberculosis. Nat Rev Immunol 2011; 11: 343-354.
16. Ruhwald M, Dominguez J, Latorre I, et al. A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb) 2011; 91: 260-267.
17. Ruhwald M, Bodmer T, Maier C, et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 2008; 32: 1607-1615.
18. Aabye MG, Ruhwald M, Praygod G, et al. Potential of interferon-c- inducible protein in improving tuberculosis diagnosis in HIV-infected patients. Eur Respir J 2010; 36: 1488-1490.
19. Kabeer BS, Sikhamani R, Raja A. Comparison of interferon-c and interferon-c-inducible protein-10 secretion in HIV-tuberculosis patients. AIDS 2010; 24: 323-325.
20. Kabeer BS, Sikhamani R, Raja A. Comparison of interferon-c-inducible protein-10 and interferon-c-based QuantiFERON TB Gold assays with tuberculin skin test in HIV-infected subjects. Diagn Microbiol Infect Dis 2011; 71: 236-243.
21. Vanini V, Petruccioli E, Gioia C, et al. IP-10 is an additional marker for tuberculosis (TB) detection in HIVinfected persons in a low-TB endemic country. J Infect 2012; 65: 49-59.
22. Goletti D, Raja A, Syed Ahamed Kabeer B, et al. Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? PLoS One 2010; 5: e12577.
23. Chen D-Y, Shen G-H, Chen Y-M, et al. Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis. Int J Tuberc Lung Dis 2011; 15: 192-200.
24. Lighter J, Rigaud M, Huie M, et al. Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children. Int J Tuberc Lung Dis 2009; 13: 731-736.
25. Ruhwald M, Petersen J, Kofoed K, et al. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One 2008; 3: e2858.
26. Yassin MA, Petrucci R, Garie KT, et al. Can interferon-c or interferon-c-induced-protein-10 differentiate tuberculosis infection and disease in children of high endemic areas? PLoS One 2011; 6: e23733.
27. Alsleben N, Ruhwald M, Ru?ssmann H, et al. Interferon-c inducible protein as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study. Scand J Infect Dis 2012; 44: 256-262.
28. Snijdewind IJM, van Kampen JJA, Fraaij PLA, et al. Current and future applications of dried blood spots in viral disease management. Antiviral Res 2012; 93: 309-321.
29. Levy PA. An overview of newborn screening. J Dev Behav Pediatr 2010; 31: 622-631.
30. Skogstrand K, Thorsen P, Nørgaard-Pedersen B, et al. Simultaneous measurement of inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 2005; 51: 1854-1866.
31. Eising S, Svensson J, Skogstrand K, et al. Type diabetes risk analysis on dried blood spot samples from population-based newborns: design and feasibility of an unselected case-control study. Paediatr Perinat Epidemiol 2007; 21: 507-517.
32. Skogstrand K, Thysen AH, Jørgensen CS, et al. Antigen-induced cytokine and chemokine release test for tuberculosis infection using adsorption of stimulated whole blood on filter paper and multiplex analysis. Scand J Clin Lab Invest 2012; 72: 204-211.
33. Skogstrand K. Multiplex assays of inflammatory markers, a description of methods and discussion of precautions - our experience through the last ten years. Methods 2012; 56: 204-212.
34. Ruhwald M, Andersen ES, Christensen PB, et al. IP-10 can be measured in dried plasma spots in patients with chronic hepatitis C infection. PLoS One 2012; 7: e45181.
35. Bélard E, Semb S, Ruhwald M, et al. Prednisolone treatment affects the performance of the QuantiFERON gold intube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection. Inflamm Bowel Dis 2011; 17: 2340-2349.
36. Pai M, Dheda K, Cunningham J, et al. T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis 2007; 7: 428-438.
37. Zhou X-H, Obuchowski NA, McClish DK. Statistical Methods in Diagnostic Medicine. 1st Edn. Hoboken, Wiley- Interscience, 2002.
38. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354.
39. Mori T. Specific detection of tuberculosis infection: an interferon-c-based assay using new antigens. Am J Respir Crit Care Med 2004; 170: 59-64.
40. Streeton JA, Desem N, Jones SL. Sensitivity and specificity of a c-interferon blood test for tuberculosis infection. Int J Tuberc Lung Dis 1998; 2: 443-450.
41. Syed Ahamed Kabeer B, Raman B, Thomas A, et al. Role of QuantiFERON-TB Gold, interferon c inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS One 2010; 5: e9051.
42. Kabeer BSA, Raja A, Raman B, et al. IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy. BMC Infect Dis 2011; 11: 135.